Antimycobacterial pyridine carboxamides: From design to in vivo activity-Reference-Cited by-同舟云学术

Antimycobacterial pyridine carboxamides: From design to in vivo activity

Published:2023-10 Issue: Volume:258 Page:115617
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Nawrot Daria Elżbieta^ORCID,Bouz Ghada^ORCID,Janďourek Ondřej,Konečná Klára,Paterová Pavla,Bárta Pavel,Novák Martin,Kučera Radim,Zemanová Júlia,Forbak Martin,Korduláková Jana,Pavliš Oto,Kubíčková Pavla,Doležal Martin,Zitko Jan

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference33 articles.

1. WHO Consolidated Guidelines on Tuberculosis. Module 5: Management of Tuberculosis in Children and Adolescents,2022

2. Facile synthesis and pesticidal activity of substituted heterocyclic pyridine compounds;Abdel-Raheem;Rev. Roum. Chem.,2022

3. Antimicrobial polycarbonates: investigating the impact of nitrogen-containing heterocycles as quaternizing agents;Ng;Macromolecules,2014

4. Prescribed drugs containing nitrogen heterocycles: an overview;Heravi;RSC Adv.,2020

5. Effects of isoniazid on mycolic acid synthesis in Mycobacterium tuberculosis and on its cell envelope;Winder;Biochem. J.,1970

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrids of 4-aminosalicylic acid with dual anti-mycobacterial and anti-inflammatory activities: Synthesis, biological evaluation, in silico investigation and structure-activity relationships exploration;Journal of Molecular Structure;2024-12

2. Design and synthesis of Thieno[3, 2-b]pyridinone derivatives exhibiting potent activities against Mycobacterium tuberculosis in vivo by targeting Enoyl-ACP reductase;European Journal of Medicinal Chemistry;2024-12

3. Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase (TMPK mt ) inhibition activity and molecular modelling studies;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-09-11

4. Unexpected influence of metallamacrocyclic architecture of heterometallic pyrazinehydroximate Cu(II)-Bi(III) and Cu(II)-La(III) complexes on their antibacterial activity against Mycolicibacterium smegmatis;Inorganica Chimica Acta;2024-05

5. Discovery of novel tetrahydrobenzothiophene derivatives as MSBA inhibitors for antimicrobial agents;Bioorganic Chemistry;2024-01